S. A. Danner

4.1k citations
48 papers · 2.7k · h-index 22

Impact in

  • Virology top 0.2%
    • HIV Research and Treatment
  • Infectious Diseases top 1%
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

  • Epidemiology 18
    • Pneumocystis jirovecii pneumonia detection and treatment 9
    • Cytomegalovirus and herpesvirus research 6
  • Infectious Diseases 16
    • HIV/AIDS Research and Interventions 10
    • HIV/AIDS drug development and treatment 10
Co-authors
Joep M. A. Lange (18 shared papers)Jaap Goudsmit (4 shared papers)Jan Karel M. Eeftinck Schattenkerk (5 shared papers)Jaap Goudsmit (5 shared papers)R A Coutinho (3 shared papers)J. van der Noordaa (3 shared papers)F. de Wolf (2 shared papers)J. M. A. Lange (4 shared papers)
Journals
Clinical Infectious Diseases (3 papers)British Journal of Haematology (2 papers)Sexually Transmitted Infections (2 papers)AIDS (2 papers)The Journal of Infectious Diseases (2 papers)
Partner nations
NetherlandsVietnamFrance

In The Last Decade

S. A. Danner

45 papers receiving 2.6k citations

Peers

S. A. Danner
Comparison fields: 5 of 100
  • Virology 1.6k
  • Infectious Diseases 1.3k
  • Emergency Medicine 326
  • Immunology 536
  • Epidemiology 636
Replace Linda L. Jagodzinski with:
Linda L. Jagodzinski United States
Frank Miedema Netherlands
Giuseppe Tambussi Italy
Gene M. Shearer United States
Jacques Leibowitch France
Barry M. Bredt United States
Parunag Nishanian United States
Ethan Bornstein United States
Giuseppe Nunnari Italy
Tedi E. Asher United States
S. A. Danner relative to Linda L. Jagodzinski United States Linda L. Jagodzinski's profile →
Citations per field
00.5×1.5×
Linda L. Jagodzinski · 1×
Citations per year

Countries citing papers authored by S. A. Danner

Since Specialization
Citations

This map shows the geographic impact of S. A. Danner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. A. Danner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. A. Danner more than expected).

Fields of papers citing papers by S. A. Danner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. A. Danner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. A. Danner. The network helps show where S. A. Danner may publish in the future.

Co-authors

The 25 scholars most cited alongside S. A. Danner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. A. Danner Line = papers co-authored together S. A. Danner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)
The Journal of Infectious Diseases ·Rob Schuurman, Monique Nijhuis, Remko van Leeuwen, P Schipper, Daphne de Jong, P. Collis, S. A. Danner, Jan W. Mulder, Clive Loveday, Cindy Christopherson, Shirley Kwok, John J. Sninsky, Charles A. Boucher
1995438
2
Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.
Journal of Clinical Investigation ·Frank Miedema, A Petit, Fokke G. Terpstra, Jan Karel M. Eeftinck Schattenkerk, F. de Wolf, Bert J. M. Al, Marijke Roos, Joep M. A. Lange, S. A. Danner, Jaap Goudsmit
1988405
3
Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
BMJ ·J. M. A. Lange, Deborah A. Paul, Han G. Huisman, F de Wolf, Henk van den Berg, R A Coutinho, S. A. Danner, J. van der Noordaa, Jaap Goudsmit
1986293
4
Declining incidence of AIDS dementia complex after introduction of zidovudine treatment.
BMJ ·Peter Portegies, Jan de Gans, Joep M. A. Lange, M.M.A. Derix, Hans Speelman, Margreet Bakker, S. A. Danner, Jaap Goudsmit
1989195
5
The Second-Generation Active A  Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Journal of Neuroscience ·Christoph Wießner, Karl‐Heinz Wiederhold, Alain C. Tissot, Pascal Frey, S. A. Danner, Laura H. Jacobson, Gary T. Jennings, Rainer M. Lüönd, R. Ortmann, Julia Reichwald, Mauro Zurini, Anis K. Mir, Martin F. Bachmann, M. Staufenbiel
2011161
6
Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.
BMJ ·Joep M. A. Lange, R A Coutinho, W Krone, L. F. Verdonck, S. A. Danner, J. van der Noordaa, Jaap Goudsmit
1986147
7
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection
AIDS ·Marc van der Valk, Elizabeth H. Gisolf, Peter Reiss, Ferdinand W.N.M. Wit, Anthony J. Japour, Gerrit Jan Weverling, S. A. Danner
2001138
8
Epidemiology of AIDS Dementia Complex in Europe
Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Antonio Chiesi, Stefano Vella, Len Dally, C Pedersen, S. A. Danner, Margaret Johnson, Stephan Schwander, F. D. Goebel, M. P. Glauser, Francisco Antunes
1996110
9
Conversion Rate towards a Syncytium‐Inducing (SI) Phenotype during Different Stages of Human Immunodeficiency Virus Type 1 Infection and Prognostic Value of SI Phenotype for Survival after AIDS Diagnosis
The Journal of Infectious Diseases ·M. Koot, (unknown), R. E. Y. de Goede, Ireneus P.M. Keet, S. A. Danner, Jan Karel M. Eeftinck Schattenkerk, Peter Reiss, M Tersmette, J. M. A. Lange, Hanneke Schuitemaker
199986
10
Autoimmunity against blood cells in human immunodeficiency-virus (HIV) infection
British Journal of Haematology ·J. van der Lelie, Joep M. A. Lange, J. J. E. Vos, C. M. van Dalen, S. A. Danner, A. E. G. Kr. Borne
198780
11
Risk Factors for Hepatotoxicity in HIV-1--Infected Patients Receiving Ritonavir and Saquinavir with or without Stavudine
Clinical Infectious Diseases ·Elizabeth H. Gisolf, Christa Dreezen, S. A. Danner, Jan Weel, Gerrit Jan Weverling, (unknown)
200076
12
Protease inhibitors atazanavir, lopinavir and ritonavir are potent blockers, but poor substrates, of ABC transporters in a broad panel of ABC transporter-overexpressing cell lines
Journal of Antimicrobial Chemotherapy ·Wouter F.W. Bierman, George L. Scheffer, A. Schoonderwoerd, Gerrit Jansen, Michiel A. van Agtmael, S. A. Danner, Rik J. Scheper
201069
13
Echocardiographic dimensions and maximal oxygen uptake in oarsmen during training.
Heart ·Wouter Wieling, E. A. M. Borghols, A. P. Hollander, S. A. Danner, Arend J. Dunning
198164
14
Decline of antibody reactivity to outer viral core protein p17 is an earlier serological marker of disease progression in human immunodeficiency virus infection than anti-p24 decline.
PubMed ·Joep M. A. Lange, Frank de Wolf, W Krone, S. A. Danner, R A Coutinho, Jaap Goudsmit
198763
15
Epidemiology of cryptosporidiosis among European AIDS patients.
Sexually Transmitted Infections ·C. Pedersen, S. A. Danner, Adriano Lazzarin, M. P. Glauser, Rainer Weber, Christine Katlama, Simon Barton, Jens Lundgren
199644
16
Therapy for cytomegalovirus polyradiculomyelitis in patients with AIDS: treatment with ganciclovir.
PubMed ·Jan de Gans, Peter Portegies, Germ Tiessens, Dirk Troost, S. A. Danner, Joep M. A. Lange
199033
17
Serological and polymerase chain reaction-based analysis of aqueous humour samples in patients with AIDS and necrotizing retinitis.
PubMed ·Frank D. Verbraak, M Galema, G H van den Horn, Marcel Bruinenberg, L. Luyendijk, S. A. Danner, Aize Kijlstra
199629
18
Combined zidovudine and interferon‐alpha treatment in patients with AIDS‐associated Kaposi's sarcoma
Journal of Internal Medicine ·Ronald de Wit, S. A. Danner, Piet Bakker, Joep M. A. Lange, Jan Karel M. Eeftinck Schattenkerk, C.H.N. Veenhof
199128
19
Factors Associated with the Development of Pneumocystis carinii Pneumonia in 5,025 European Patients with AIDS
Clinical Infectious Diseases ·Jens Lundgren, Simon Barton, Adriano Lazzarin, S. A. Danner, F. D. Goebel, Per Olav Pehrson, F Mulcahy, J. Kosmidis, C Pedersen, Andrew Phillips, (unknown)
199527
20
Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients
British Journal of Ophthalmology ·G. J. van den Horn, Christina Meenken, S. A. Danner, (unknown), Marc D. de Smet
199826

About S. A. Danner

S. A. Danner is a scholar working on Epidemiology, Infectious Diseases, Virology, Immunology and Oncology, having authored 48 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (13 papers), HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Immunodeficiency and Autoimmune Disorders (7 papers), Cytomegalovirus and herpesvirus research (6 papers), HIV-related health complications and treatments (5 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (1.3k citations), Emergency Medicine (326 citations), Immunology (536 citations) and Epidemiology (636 citations). S. A. Danner has collaborated with scholars based in Netherlands, Vietnam and France. Frequent co-authors include Joep M. A. Lange, Jaap Goudsmit, Jan Karel M. Eeftinck Schattenkerk, Jaap Goudsmit, R A Coutinho, J. van der Noordaa, F. de Wolf, J. M. A. Lange, Frank Miedema and Marijke Roos. Their work appears in journals such as Clinical Infectious Diseases, British Journal of Haematology, Sexually Transmitted Infections, AIDS and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda L. JagodzinskiBreakdown of academic impact, for papers by Frank MiedemaBreakdown of academic impact, for papers by Giuseppe TambussiBreakdown of academic impact, for papers by Gene M. ShearerBreakdown of academic impact, for papers by Jacques LeibowitchBreakdown of academic impact, for papers by Barry M. BredtBreakdown of academic impact, for papers by Parunag NishanianBreakdown of academic impact, for papers by Ethan BornsteinBreakdown of academic impact, for papers by Giuseppe NunnariBreakdown of academic impact, for papers by Tedi E. Asher